Nature Communications (Jan 2023)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model

  • Jamal B. Williams,
  • Qing Cao,
  • Wei Wang,
  • Young-Ho Lee,
  • Luye Qin,
  • Ping Zhong,
  • Yong Ren,
  • Kaijie Ma,
  • Zhen Yan

DOI
https://doi.org/10.1038/s41467-022-35749-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 13

Abstract

Read online

The study by Williams et al shows targeting the aberrant histone modifying enzyme Smyd3 rescues NMDAR and cognitive deficits in a mouse model of Alzheimer’s disease. It highlights the potential of epigenetic treatment in neurodegenerative diseases.